Personalized dosimetry for a deeper understanding of metastatic response to high activity 131I-mIBG therapy in high risk relapsed refractory neuroblastoma

BACKGROUNDDosimetry in molecular radiotherapy for personalized treatment is assuming a central role in clinical management of aggressive/relapsed tumors. Relapsed/refractory metastatic high-risk neuroblastoma (rrmHR-NBL) has a poor prognosis and high-activity 131I-mIBG therapy could represent a prom...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Quantitative imaging in medicine and surgery 2022-02, Vol.12 (2), p.1299-1310
Hauptverfasser: Cassano, Bartolomeo, Pizzoferro, Milena, Valeri, Silvio, Polito, Claudia, Donatiello, Salvatore, Altini, Claudio, Villani, Maria Felicia, Serra, Annalisa, Castellano, Aurora, Garganese, Maria Carmen, Cannatà, Vittorio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!